- Home
- Lobbying firms
- The Mcmanus Group
The Mcmanus Group
Lobbying firm · Jul 2025 – Sep 2026
The Mcmanus Group earned $5.1M lobbying for 25 clients (Jul 2025 – Sep 2026). Biggest clients: Infusion Providers Alliance, Large Urology Group Practice Association, Amgen.
- Lobbying income
- $5.1M
- Clients
- 25
Clients
- Infusion Providers Alliance$360K
- Large Urology Group Practice Association$360K
- Amgen$240K
- Ambulatory Surgery Center Association$240K
- Gilead Sciences, Inc.$240K
- National Association Of Freestanding Emergency Centers$240K
- Pharmaceutical Research And Manufacturers Of America$240K
- Ardelyx, Inc.$240K
- Bristol-Myers Squibb Company$240K
- Acesso Biologics$230K
- Genentech, Inc.$200K
- Grail, Inc.$200K
- Wex Health$200K
- Vivex Biologics$200K
- Biowound Solutions$200K
- Zimmer Biomet, Inc.$200K
- The American Occupational Therapy Association, Inc.$160K
- Roche Diagnostics$160K
- Vialase Inc.$150K
- Owlet$140K
- Fulcrum Therapeutics$130K
- Dendreon Pharmaceuticals LLC$120K
- Medical Device Manufacturers Association$120K
- Sight Sciences$100K
- Royal Biologics$90K
More
From Lobbying Disclosure Act reports.
Cite or embed this page
Capitol Receipts, “The Mcmanus Group: Lobbying Firm Clients & Income,” https://www.capitolreceipts.com/lobbying-firm/fthemcmanusgroup/the-mcmanus-group (accessed 2026-10-16).